Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:education |
gptkb:University_of_California,_Berkeley
gptkb:Yale_University |
| gptkbp:employer |
gptkb:Vertex_Pharmaceuticals
gptkb:Relay_Therapeutics |
| https://www.w3.org/2000/01/rdf-schema#label |
Mark Murcko
|
| gptkbp:knownFor |
drug discovery
structure-based drug design |
| gptkbp:memberOf |
gptkb:American_Association_for_the_Advancement_of_Science
gptkb:American_Chemical_Society |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notableWork |
development of HIV protease inhibitors
development of hepatitis C drugs |
| gptkbp:occupation |
gptkb:business_executive
chemist |
| gptkbp:position |
Chief Technology Officer
Chief Scientific Officer |
| gptkbp:bfsParent |
gptkb:Relay_Therapeutics
|
| gptkbp:bfsLayer |
6
|